| Ramesh Gulrajani, MD | |
|
240 Willoughby St, Suite 7f, Brooklyn, NY 11201 | |
| (718) 250-6100 | |
| (718) 250-6110 |
| Full Name | Ramesh Gulrajani |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 49 Years |
| Location | 240 Willoughby St, Brooklyn, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801901327 | NPI | - | NPPES |
| 00561546 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 136710 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Brooklyn Hospital Center - Downtown Campus | Brooklyn, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tbhc Physician Services Pc | 9133265317 | 90 |
News Archive
Genmab A/S announced today plans to begin four studies of ofatumumab in chronic lymphocytic leukemia (CLL) and follicular non-Hodgkin's lymphoma (NHL) this year.
The World Health Organization and the International Development Innovation Alliance today signed a strategic Collaborative Agreement to support the scaling of health innovations.
Improved screening and detection efforts, combined with decreases in risk factors like smoking, have reduced the incidence and mortality rates from several common types of cancer in many high-income countries. However, many low-and middle-income countries have seen cancer rates rise, partially due to increases in risk factors that are typical of Western countries.
Physicians can now be alerted to pediatric patients' risk of sudden unexpected death in epilepsy, or SUDEP, during routine primary care visits by using software developed and commercialized by a researcher-entrepreneur at the Indiana University School of Medicine.
› Verified 3 days ago
| Entity Name | Tbhc Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417183963 PECOS PAC ID: 9133265317 Enrollment ID: O20091202000714 |
News Archive
Genmab A/S announced today plans to begin four studies of ofatumumab in chronic lymphocytic leukemia (CLL) and follicular non-Hodgkin's lymphoma (NHL) this year.
The World Health Organization and the International Development Innovation Alliance today signed a strategic Collaborative Agreement to support the scaling of health innovations.
Improved screening and detection efforts, combined with decreases in risk factors like smoking, have reduced the incidence and mortality rates from several common types of cancer in many high-income countries. However, many low-and middle-income countries have seen cancer rates rise, partially due to increases in risk factors that are typical of Western countries.
Physicians can now be alerted to pediatric patients' risk of sudden unexpected death in epilepsy, or SUDEP, during routine primary care visits by using software developed and commercialized by a researcher-entrepreneur at the Indiana University School of Medicine.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ramesh Gulrajani, MD Po Box 30223, New York, NY 10087 Ph: (845) 634-6500 | Ramesh Gulrajani, MD 240 Willoughby St, Suite 7f, Brooklyn, NY 11201 Ph: (718) 250-6100 |
News Archive
Genmab A/S announced today plans to begin four studies of ofatumumab in chronic lymphocytic leukemia (CLL) and follicular non-Hodgkin's lymphoma (NHL) this year.
The World Health Organization and the International Development Innovation Alliance today signed a strategic Collaborative Agreement to support the scaling of health innovations.
Improved screening and detection efforts, combined with decreases in risk factors like smoking, have reduced the incidence and mortality rates from several common types of cancer in many high-income countries. However, many low-and middle-income countries have seen cancer rates rise, partially due to increases in risk factors that are typical of Western countries.
Physicians can now be alerted to pediatric patients' risk of sudden unexpected death in epilepsy, or SUDEP, during routine primary care visits by using software developed and commercialized by a researcher-entrepreneur at the Indiana University School of Medicine.
› Verified 3 days ago
Dr. Alexander Usorov, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 447 Atlantic Ave, Brooklyn, NY 11217 Phone: 718-858-6300 | |
Dr. Marcellus Andre Walker, MD Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 2094 Pitkin Ave, Brooklyn, NY 11207 Phone: 718-240-0516 Fax: 718-240-0564 | |
Lotus Ahmed, D.O Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 518 Mcdonald Ave, Brooklyn, NY 11218 Phone: 917-848-5432 Fax: 347-252-6754 | |
Mrs. Sophia Schwartzman, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2700 Ocean Avenue, Brooklyn, NY 11229 Phone: 518-587-1141 | |
Dr. Haitham M Ahmed, MD, MPH Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 101 Pennsylvania Avenue, Brooklyn, NY 11207 Phone: 718-240-2000 Fax: 718-240-2260 | |
Yanjin Yang, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 506 6th St, Brooklyn, NY 11215 Phone: 718-780-3000 | |
Ashwad Afzal, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 506 6th St, Brooklyn, NY 11215 Phone: 718-780-5246 |